Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Department of Radiology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Eur Radiol. 2021 Jun;31(6):3627-3637. doi: 10.1007/s00330-020-07499-w. Epub 2020 Nov 19.
Patients with hepatocellular carcinoma (HCC) receiving different treatments might have specific prognostic factors that can be captured in the hepatobiliary phase (HBP) of gadoxetic acid-enhanced magnetic resonance imaging (GA-MRI). We aimed to identify the clinical findings and HBP features with prognostic value in patients with HCC.
In this retrospective, single-institution study, we included patients with Barcelona Clinic Liver Cancer very early/early stage HCC who underwent GA-MRI before treatment. After performing propensity score matching, 183 patients received the following treatments: resection, radiofrequency ablation (RFA), and transarterial chemoembolization (TACE) (n = 61 for each). Cox regression models were used to identify clinical factors and HBP features associated with disease-free survival (DFS) and overall survival (OS).
In the resection group, large tumor size was associated with poor DFS (hazard ratio [HR] 4.159 per centimeter; 95% confidence interval [CI], 1.669-10.365) and poor OS (HR 8.498 per centimeter; 95% CI, 1.072-67.338). In the RFA group, satellite nodules on HBP images were associated with poor DFS (HR 5.037; 95% CI, 1.061-23.903) and poor OS (HR 9.398; 95% CI, 1.480-59.668). Peritumoral hypointensity on HBP images was also associated with poor OS (HR 13.062; 95% CI, 1.627-104.840). In addition, serum albumin levels and the prothrombin time-international normalized ratio were associated with DFS and/or OS. Finally, in the TACE group, no variables were associated with DFS/OS.
Different HBP features and clinical factors were associated with DFS/OS among patients with HCC receiving different treatments.
• In patients who underwent resection for HCC, a large tumor size on HBP images was associated with poor disease-free survival and overall survival. • In the RFA group, satellite nodules and peritumoral hypointensity on HBP images, along with decreased serum albumin levels and PT-INR, were associated with poor disease-free survival and/or overall survival. • In the TACE group, no clinical or HBP imaging features were associated with disease-free survival or overall survival.
接受不同治疗的肝细胞癌 (HCC) 患者可能具有可在钆塞酸增强磁共振成像 (GA-MRI) 的肝胆期 (HBP) 中捕获的特定预后因素。我们旨在确定在 HCC 患者中具有预后价值的临床发现和 HBP 特征。
在这项回顾性、单机构研究中,我们纳入了在治疗前接受 GA-MRI 检查的巴塞罗那临床肝癌非常早期/早期 HCC 患者。在进行倾向评分匹配后,183 名患者接受了以下治疗:切除术、射频消融术 (RFA) 和经动脉化疗栓塞术 (TACE)(每组 61 名)。Cox 回归模型用于确定与无疾病生存率 (DFS) 和总生存率 (OS) 相关的临床因素和 HBP 特征。
在切除术组中,肿瘤较大与 DFS 不良相关 (每厘米风险比 [HR] 4.159;95%置信区间 [CI],1.669-10.365) 和 OS 不良相关 (HR 每厘米 8.498;95%CI,1.072-67.338)。在 RFA 组中,HBP 图像上的卫星结节与 DFS 不良相关 (HR 5.037;95%CI,1.061-23.903) 和 OS 不良相关 (HR 9.398;95%CI,1.480-59.668)。HBP 图像上的肿瘤周围低信号强度也与 OS 不良相关 (HR 13.062;95%CI,1.627-104.840)。此外,血清白蛋白水平和凝血酶原时间国际标准化比值与 DFS 和/或 OS 相关。最后,在 TACE 组中,没有变量与 DFS/OS 相关。
不同的 HBP 特征和临床因素与接受不同治疗的 HCC 患者的 DFS/OS 相关。
在接受 HCC 切除术的患者中,HBP 图像上的大肿瘤大小与无疾病生存率和总生存率不良相关。
在 RFA 组中,HBP 图像上的卫星结节和肿瘤周围低信号强度以及血清白蛋白水平和 PT-INR 降低与无疾病生存率和/或总生存率不良相关。
在 TACE 组中,没有临床或 HBP 成像特征与无疾病生存率或总生存率相关。